|
- 2017
CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapyDOI: 10.1080/2162402X.2016.1273302 Keywords: Adoptive T-cell therapy, breast cancer, immunosuppression, lung cancer, mesothelioma, PD-1 blockade, tumor microenvironment Abstract: PD-L1/2 expression in solid tumors inhibits chimeric antigen receptor (CAR) T-cell efficacy. A PD-1 dominant negative receptor expressed in CAR T cells provides cell-intrinsic checkpoint blockade and augments antitumor efficacy. A combinatorial immunotherapeutic strategy of combining CAR T cells with checkpoint blockade is a promising treatment approach for solid tumors
|